Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Alterity Therapeutics Announces New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer's and Parkinson's

prnasiaAugust 05, 2021

Tag: Alterity , ATH434 , Parkinson's , Alzheimer's

PharmaSources Customer Service